Huahai Pharma Obtains $14 Million in US Tariff Refunds
() -- Zhejiang Huahai Pharmaceutical (SHA:600521) received tariff refunds worth $14.2 million through its subsidiary ScieGen Health USA, according to a Shanghai bourse filing on Thursday. The tariff refunds came after the U.S. Supreme Court ruled that the U.S. government's tariff measures were invalid and the amount sh